Anna Olsson‐Brown

3.1k citations
50 papers · 589 · h-index 13

Impact in

  • Oncology top 10%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Colorectal Cancer Treatments and Studies
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses

Papers in

    • Cancer Immunotherapy and Biomarkers 22
    • CAR-T cell therapy research 6
    • Colorectal Cancer Treatments and Studies 6
    • Immunotherapy and Immune Responses 5
    • Immune Cell Function and Interaction 3

Anna Olsson‐Brown

46 papers receiving 582 citations

Peers

Anna Olsson‐Brown
Comparison fields: 5 of 87
  • Oncology 248
  • Immunology 83
  • Pharmacology 61
  • Emergency Medical Services 19
  • Neurology 38
Replace Patrick J. Kiel with:
Patrick J. Kiel United States
Chang Lu China
E De Cock United Kingdom
Theresa Foster United Kingdom
Christine Nguyen United States
Jennifer E. Schwartz United States
Manuela Giangreco Italy
Renee L. Gennarelli United States
Michael O’Sullivan Australia
Nitin Chopra United States
Anna Olsson‐Brown relative to Patrick J. Kiel United States Patrick J. Kiel's profile →
Citations per field
00.5×5.5×
Patrick J. Kiel · 1×
Citations per year

Countries citing papers authored by Anna Olsson‐Brown

Since Specialization
Citations

This map shows the geographic impact of Anna Olsson‐Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Olsson‐Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Olsson‐Brown more than expected).

Fields of papers citing papers by Anna Olsson‐Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Olsson‐Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Olsson‐Brown. The network helps show where Anna Olsson‐Brown may publish in the future.

Co-authors

The 25 scholars most cited alongside Anna Olsson‐Brown, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna Olsson‐Brown Line = papers co-authored together Anna Olsson‐Brown links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.

#Work
1 201995
2 201894
3 202059
4 202135
5 202030
6 202128
7 201927
8 202023
9 202019
10 202017
11 202216
12 202216
13 202114
14 202011
15 202411
16 201710
17 20238
18 20247
19 20217
20 20206

About Anna Olsson‐Brown

Anna Olsson‐Brown is a scholar working on Oncology, Immunology, Genetics, Biotechnology and Pharmacology, having authored 50 papers that have together received 589 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (22 papers), Virus-based gene therapy research (7 papers), CAR-T cell therapy research (6 papers), Colorectal Cancer Treatments and Studies (6 papers), Cancer Research and Treatments (6 papers), Immunotherapy and Immune Responses (5 papers), Drug-Induced Adverse Reactions (5 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Oncology (248 citations), Immunology (83 citations), Pharmacology (61 citations), Emergency Medical Services (19 citations) and Neurology (38 citations). Anna Olsson‐Brown has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Bryan D. Jones, Emma Vaux, Joseph J. Sacco, Munir Pirmohamed, James Larkin, Claire Higham, Peter Trainer, Tim Cooksley, Paul Lorigan and Paul Carroll. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Endocrine Connections, Annals of Oncology and Journal of Crohn s and Colitis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact